Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/8091| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Poposka, Lidija | en_US |
| dc.date.accessioned | 2020-05-11T13:32:50Z | - |
| dc.date.available | 2020-05-11T13:32:50Z | - |
| dc.date.issued | 2013-07-15 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/8091 | - |
| dc.description.abstract | Novel oral anticoagulants are safer than Vitamin K antagonists (warfarin) in respect to the occurrence of bleeding, especially in terms of intracranial hemorrhage. Furthermore they are non-inferior and to a certain degree are superior in comparison to warfarin, when it comes to the prevention of ischemic stroke in patients with atrial fibrillation (AF). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | European Society of Cardiology | en_US |
| dc.relation.ispartof | e-Journal of Cardiology Practice | en_US |
| dc.subject | atrial fibrillation | en_US |
| dc.title | Novel anticoagulants in atrial fibrillation: focused update | en_US |
| dc.type | Article | en_US |
| dc.identifier.volume | 11 | - |
| dc.identifier.issue | 26 | - |
| item.fulltext | With Fulltext | - |
| item.grantfulltext | open | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Novel anticoagulants in atrial fibrillation focused update.pdf | 114.5 kB | Adobe PDF |  View/Open |
Page view(s)
365
checked on Nov 25, 2025
Download(s)
30
checked on Nov 25, 2025
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.